Photo by omarprestwich from unsplash
CONCLUSION ASO and siRNA agents targeting Lp(a) appear to be promising treatment options for patients with elevated Lp(a) in addition to the classical therapies with statins or other cholesterol lowering… Click to show full abstract
CONCLUSION ASO and siRNA agents targeting Lp(a) appear to be promising treatment options for patients with elevated Lp(a) in addition to the classical therapies with statins or other cholesterol lowering drugs.
Keywords:
forward atherosclerosis;
another step;
step forward;
lipoprotein lowering;
lowering medications;
medications another
Journal Title: Journal of cardiovascular pharmacology
Year Published: 2023
Link to full text (if available)
Share on Social Media: Sign Up to like & get
recommendations!
Journal Title: Journal of cardiovascular pharmacology
Year Published: 2023
Link to full text (if available)
Share on Social Media: Sign Up to like & get
recommendations!